Medpace Holdings
$598.08Change from previous close: −4.18%Absolute change: −$26.10
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $16.69B
- Enterprise value
- $16.33B
- P/E (trailing 12 months)
- 36.6
- Forward P/E
- 31.0
- PEG
- 2.97
- Price/book
- 38.5
- Price/sales
- 6.00
- EV/EBITDA
- 26.7
- EV/revenue
- 5.87
Profitability and growth
- Gross margin
- 72.4%
- Operating margin
- 20.8%
- Net margin
- 17.7%
- ROE
- 162.2%
- ROA
- 20.1%
- Revenue growth (year over year)
- 17.2%
- Earnings growth (year over year)
- 37.1%
Financial health
- Total cash
- $502.69M
- Total debt
- $144.11M
- Debt/equity
- 0.33
- Current ratio
- 0.73
- Quick ratio
- 0.66
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $589.92
- Median price target
- $609.00
- High price target
- $692.00
- Low price target
- $370.00
- Analysts with a price target
- 13
- Consensus
- Hold
- Forward EPS
- $19.31
- EPS estimate, current year
- $17.70
Shares and trading
- Beta
- 1.15
- Average volume
- 278.3K
- Shares outstanding
- 27.91M
- Float
- 22.61M
- Institutional ownership
- 91.2%
- Insider ownership
- 18.9%
- Short interest (% of float)
- 7.5%
- Short ratio (days)
- 8.45